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Engineering clinically relevant cells in vitro holds
promise for regenerative medicine, but most pro-
tocols fail to faithfully recapitulate target cell pro-
perties. To address this, we developed CellNet, a
network biology platform that determines whether
engineered cells are equivalent to their target tis-
sues, diagnoses aberrant gene regulatory networks,
and prioritizes candidate transcriptional regulators
to enhance engineered conversions. Using CellNet,
we improved B cell to macrophage conversion, tran-
scriptionally and functionally, by knocking down
predicted B cell regulators. Analyzing conversion of
fibroblasts to induced hepatocytes (iHeps), CellNet
revealed an unexpected intestinal program regulated
by the master regulator Cdx2. We observed long-
term functional engraftment of mouse colon by
iHeps, thereby establishing their broader potential
as endoderm progenitors and demonstrating direct
conversion of fibroblasts into intestinal epithelium.
Our studies illustrate how CellNet can be employed
to improve direct conversion and to uncover unap-
preciated properties of engineered cells.
INTRODUCTION
The in vitro manufacture of clinically relevant cells offers a po-
tential strategy for regenerative therapy and permits disease
modeling, toxicology testing, and drug discovery. Current
approaches aim to engineer cell identity by means of directed
differentiation from a pluripotent state or by transcription fac-
tor-driven conversion between differentiated states (Morris andDaley, 2013; Vierbuchen and Wernig, 2011). Directed differenti-
ation typically comprises multiple steps, is time-consuming
and inefficient, and commonly yields immature cells correspond-
ing to embryonic counterparts rather than mature adult cells
(Cohen and Melton, 2011). By comparison, direct conversion is
relatively straightforward and rapid, but there is evidence for
incomplete conversion, especially between divergent cell types
(Morris and Daley, 2013; Willenbring, 2011).
Many examples of direct conversion between differentiated
states have been reported in mouse and human, for example,
from fibroblasts to cardiomyocytes, hepatocytes, and neurons
(Huang et al., 2011; Ieda et al., 2010; Sekiya and Suzuki, 2011;
Son et al., 2011; Vierbuchen et al., 2010). More recently, several
groups have described direct conversion to progenitor states,
including hematopoietic, neuronal, and hepatic progenitors (Lu-
jan et al., 2012; Pereira et al., 2013; Yu et al., 2013). These engi-
neering strategies predominantly employ transcription factor
overexpression as a means to drive fate conversion.
Current conversion strategies are often unable to fully specify
a defined cell fate. For example, hepatic gene expression is not
fully extinguished in neural cells derived from hepatocytes, and
macrophages derived from fibroblasts harbor the originating
cell signature and are prone to dedifferentiation (Feng et al.,
2008; Marro et al., 2011). Furthermore, conversion of fibroblasts
to cardiomyocytes yields cells that do not fully recapitulate
the profile of neonatal cardiomyocytes (Ieda et al., 2010). These
observations are concerning since the extent to which an
in vitro engineered cell population resembles its in vivo correlate
transcriptionally and functionally is seldom assessed in a
comprehensive or standardized manner. Measuring functional
engraftment via transplantation into animal models lacks
rigorous quantitation and the transcriptional similarity of engi-
neered cell populations is commonly assessed by expression
profiling followed by simple hierarchical clustering analysis.
Such global analyses do not provide a quantitative means forCell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc. 889
assessing deficiencies of engineered cells, nor do they provide a
systematic approach to prioritize interventions to improve fate
specification.
To address this, we developed a computational platform, Cell-
Net, which reconstructs gene regulatory networks (GRNs) using
publically available gene expression data for a range of cell types
and tissues, and then classifies engineered cells according to
establishment of GRNs for particular target cells, providing a
precise metric of cell similarity. CellNet also identifies regulatory
nodes at which engineered cells are distinct from target cells,
and provides a ranked list of transcription factors whose manip-
ulation is predicted to bring the engineered cell closer to the
target. In an accompanying study, we have analyzed expression
data for over 200 derived cell populations from 56 published re-
ports and found that cells generated through directed differenti-
ation more closely resemble their in vivo correlates compared to
cells engineered via direct conversion,mainly due to failure of the
converted cells to extinguish the expression programs of the
starting cell type. Unexpectedly, we discovered that the estab-
lishment of GRNs associated with alternate fate was common
to nearly all engineering strategies (Cahan et al., 2014).
Here, we apply CellNet to two distinct cell fate engineering
paradigms: conversion of B cells to macrophages, and fibro-
blasts to hepatocyte-like cells (iHeps). CellNet revealed that
neither strategy generated fully converted cells; B cell identity
was not extinguished in induced macrophages, whereas a
progenitor state was transiently and partially established. Engi-
neering the conversion to macrophages by knocking down Cell-
Net-prioritized candidates improved target cell fate and function.
iHeps, unlike primary hepatocytes, demonstrate impaired hepa-
tocyte function, are immortalized, and exhibit progenitor marker
expression that is extinguished following transplantation (Sekiya
and Suzuki, 2011). In agreement with this, CellNet revealed that
iHeps manifest minimal liver identity. Surprisingly, CellNet un-
veiled considerable hindgut identity harbored by iHeps, regu-
lated by Cdx2. We were able to demonstrate their long-term
functional colon engraftment, indicating that iHeps in fact repre-
sent an endoderm progenitor rather than a differentiated cell
type as previously thought. CellNet is thus a potent tool for reas-
sessing and refining established conversion protocols.
RESULTS
Application of the CellNet Network Biology Platform to
Assess Direct Conversion
GRNs govern the steady-state expression program of a partic-
ular cell type and thus act as major molecular determinants of
cell identity (Davidson and Erwin, 2006). Measuring the estab-
lishment of cell and tissue-specific GRNs in engineered popula-
tions serves as both a robust metric of cellular identity and as a
tool to detect the establishment of alternate GRNs. We designed
CellNet to classify engineered cell populations by their similarity
to target cells and tissues, to assess the extent to which target
GRNs are established, and to score transcriptional regulators
according to their likelihood of improving the engineered popula-
tion (Figure 1A). The CellNet platform is fully detailed in our
accompanying paper and is publically available (Cahan et al.,
2014, http://cellnet.hms.harvard.edu).890 Cell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc.B cell to macrophage conversion is a major paradigm for un-
derstanding principles of direct cell fate conversion (Bussmann
et al., 2009). Application ofCellNet revealed that enforced expres-
sion of the transcription factor C/EBPa converts freshly harvested
B cells into macrophages, following a time-dependent extinction
of B cell identity and acquisition of a strong, exclusive macro-
phage classification score (Di Tullio et al., 2011; mean scores, B
cell: 0.012,macrophage: 0.73; Figure 1B). In contrast to this, con-
version of a cultured pre-B cell line engineered with estradiol-
inducible C/EBPa (C10 cells, Bussmann et al., 2009; Figure 1C)
fails to fully extinguish B cell identity, yielding cells that only
partially classify as macrophages 48 hr postconversion (mean
scores: B cell: 0.65, macrophage: 0.54; Figure 1D). Interestingly,
no significant changes in DNA methylation have been observed
during this conversion, which may indicate that the C10 cell line
harbors conversion barriers unique to in vitro cultured cell lines
(Rodrı´guez-Ubreva et al., 2012). Despite this limitation, the induc-
ible C10 cell line represents a robust system to interrogate the
molecularmechanisms of direct conversion and a valuablemodel
for applying CellNet to enhance cell fate conversion.
To enable identification of GRNs that fail to extinguish or are
incompletely or aberrantly established in engineered cells, we
devised a metric of GRN status. We assessed the expression
of each gene in a GRN relative to its expected value and then
weighted each gene by its importance to the network and to
the associated cell and tissue classifier (Figure 2A). To prioritize
transcriptional regulator interventions that might improve engi-
neering strategies, we computed a network influence score
that integrates the expression level of the regulator in the target
cell or tissue, the extent of dysregulation of the regulator and its
predicted targets in the query sample, and the number of pre-
dicted targets (Figure 2B). We applied these functions of CellNet
to the estradiol-inducible C10 B cell to macrophage conversion.
Assessment of GRN status revealed that the macrophage GRN
was gradually but not completely established over 48 hr,
whereas the B cell GRN remained intact (Figure 2C). These
data were in contrast to the almost complete conversion of
native B cells (Figures 1B and S1A available online). Interestingly,
CellNet also exposed the partial and transient establishment of a
hematopoietic stem and progenitor cell (HSPC) GRN during con-
version of C10 cells (Figure 2C), and similarly in the conversion of
native B cells (Figure 1B; Di Tullio et al., 2011), raising the provoc-
ative possibility that expression of C/EBPa induces a transient
wave of progenitor GRN reactivation from which macrophages
ultimately emerge.
Engineering Cell Fate
In an attempt to improve conversion of C10-induced macro-
phages, we extended the duration of C/EBPa expression to
4 days, but neither B cell nor macrophage statuses improved,
suggesting that the partial conversion was not due to insufficient
duration of C/EBPa expression (Figure S1B). B cell GRN persis-
tence was striking in the converted cells, thus we consulted
CellNet to score transcriptional regulators of B cell identity. Cell-
Net-prioritized Pou2af1 (Pou2 associating factor 1) and Ebf1
(Early B cell factor 1) as transcriptional regulators associated
with B cell identity that remained expressed at inappropriately
high levels in the converted cells (Figure 2D). Ebf1 promotes
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Figure 1. Application of CellNet Classification to the Direct Conversion of B Cells to Macrophages
(A) Adapted from Cahan et al. (2014) We designed CellNet to query gene expression profiles of engineered cell populations to classify input samples by their
similarity to target cells and tissues, in order to assess the extent to which cell type and tissue GRNs are established and to score transcriptional regulators
according to their likelihood of improving the engineered population. GRNs were used to construct a cell type classifier which was initially used to assess
C/EBPa-mediated conversion of B cells to macrophages.
(B) Each row in the classifier represents one cell or tissue type and each column represents one expression array. Higher classification scores indicate a higher
probability that a query sample expresses the target GRN genes at a level indistinguishable from the same cell or tissue in the training data; classification heatmap
of primary B cell to macrophage conversion shows that converted cells classify exclusively as macrophages (Di Tullio et al., 2011).
(C) C10 estradiol-inducible B cell to macrophage conversion (Bussmann et al., 2009).
(D) Cell and tissue classification heatmap showing that conversion is not complete with induced macrophages maintaining B cell classification and only partially
classifying as macrophages.
See also Figure S1.B cell fate and blocks alternate fates (Nechanitzky et al., 2013),
whereas Pou2af1 coactivates Oct1 and Oct2 on B-cell-specific
promoters and is important for B cell activation and maturation
(Lins et al., 2003).
In our experiments, conversion of the C10 B cell line was highly
reproducible, with the majority of cells gaining Mac1 positivity
and losingCD19 expressionwithin 48 hr (Figure S1C). To facilitate
investigation of CellNet-enhanced conversion, we identifiedCD302 as a cell surface antigen that was inadequately expressed
on induced relative to native macrophages (Figure S1D). We then
knocked down Ebf1 or Pou2af1 using lentivirally delivered
shRNAs, resulting in an 80% reduction in target gene expres-
sion (Figure S2A). Next, we initiated conversion with b-estradiol
and after 72 hr analyzed expression of Mac1 and CD302 by
flow cytometry. Knockdown of either Ebf1 or Pou2af1 signifi-
cantly expanded the Mac1brightCD302+ population relative toCell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc. 891
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scramble shRNA-treated cells (Figure 2E). We then tested the
macrophage-associated functions ofEbf1 andPou2af1-depleted
cells. Cell migration, formation of lamellipodia and filopodia, and
phagocytosis were all significantly enhanced relative to untreated
and scramble-treated cells (Figures 2F, S2B, and S2C). Quantita-
tive PCR analysis showed a decrease in expression of some
B cell-specific genes whereas others were paradoxically upregu-
lated; however, there was a more consistent increase in macro-
phage-specific gene expression (Figure S2D). We reapplied
CellNet to the engineered cells and found that knockdown of
Ebf1 or Pou2af1 fortified their macrophage classification, corrob-
orating their improved in vitro function (Figure 2G; mean scores:
Scramble: 0.39, Ebf1 knockdown: 0.52, Pou2af1 knockdown:
0.54). However, although macrophage GRN status significantly
improved (Figure 2H: Ebf1 knockdown: p = 0.029, Pou2af1
knockdown: p = 0.011), detailed analysis revealed that the
B cell GRN was not extinguished following knockdown of these
factors, perhaps due to the existence of feedback loops reinforc-
ing B cell identity. To explore this, we searched CellNet GRNs for
regulatory loops in which Pou2af1 loss is predicted to increase B
cell factor expression. Indeed, we found several such loops,
including one connecting Pou2af1 downregulation to the upregu-
lation of the master B cell regulator Pax5, and Ebf1 itself through
Runx2 and Runx3 (Figures S2D and S2E). These data suggest
that residual expression of Ebf1 and Pou2af1 in the converted
cells serves primarily to repress macrophage fate.
We explored the possibility that Ebf1 and Pou2af1 mutually
repress myeloid-associated GRNs, as previously reported for
Ebf1 (Nechanitzky et al., 2013). Examining targets directly linked
to Ebf1/Pou2af1 in the overall GRN, as well as targets of tran-
scription factors that Ebf1/Pou2af1 target themselves, we found
that the set of macrophage genes upregulated by B cell factor
knockdown were significantly enriched in genes that CellNet
predicted to be repressed by Pou2af1 or Ebf1 (p % 0.005 and
0.05, respectively, Tables S1 and S2; Figure S2F). Thus, the
improved in vitro function of Ebf1/Pou2af1-depleted cells
following C/EBPa-induced conversion of C10 cells is at least in
part due to the repressive actions of these B cell regulators on
macrophage gene expression programs.
B cell to macrophage conversion demonstrates the utility of
CellNet to dissect cell identity and prioritize candidates to
improve fate specification iteratively. Conversion of B cells toFigure 2. Application of the CellNet GRN Status Metric and Candidate
(A) Adapted fromCahan et al. (2014) To identify cell and tissue-specific GRN estab
the closeness of the expression of each gene in a GRN to its expected value, a
importance in the associated classifier.
(B) To prioritize transcriptional regulator interventions, we devised a Network Influ
dysregulation of the regulator, and its predicted targets in the query sample, and
estradiol-inducible B cell to macrophage conversion.
(C) The B cell GRN is not extinguished and themacrophage GRN not fully establish
during conversion. Data are represented as mean ± SD.
(D) CellNet prioritization of B cell transcriptional regulators whose expression is m
(E) C/EBPa induced direct conversion of C10 B cells tomacrophages following shR
expression 3 days after conversion. The Mac1BrightCD302+ population is expand
(F) Cumulative distance migrated by induced macrophages increases following kn
10 mM. *** = p < 0.001. Data are represented as mean ± SEM.
(G and H) Cell and tissue classification heatmap following knockdowns (G) and co
Macrophage identity is fortified following knockdown. Data are represented as m
See also Figure S1 and S2 and Tables S1 and S2.macrophages represents a conversion between closely related
cells. To investigate a dramatic change in fate between more
disparate germ layers, we focused on conversion of meso-
derm-derived fibroblasts to endoderm-derived hepatocytes.
CellNet: Induced Hepatocytes Fail to Classify as Liver
Mouse embryonic fibroblast (MEF) to hepatocyte-like cell con-
version has been reported by two independent groups: Sekiya
and Suzuki employed Hnf4a, with either Foxa1, 2, or 3, while
Huang and colleagues utilized Gata4, Hnf1a, and Foxa3 in con-
cert with inactivation of p19(Arf) (Huang et al., 2011; Sekiya and
Suzuki, 2011). In both reports, the resulting induced hepatocytes
were capable of engrafting fumarylacetoacetate hydrolase-defi-
cient (Fah–/–) mice, a tyrosinemia model of liver failure. However,
unlike primary hepatocytes, iHeps demonstrated impaired hepa-
tocyte function and were unable to fully repopulate Fah–/– mice.
Liver function remained abnormal, resulting in reduced survival
rates. Curiously, iHeps were immortalized and expressed pro-
genitor markers such as Alpha-fetoprotein (Afp), whose expres-
sion ceased following transplantation (Sekiya and Suzuki, 2011).
We reproduced the Sekiya and SuzukiMEF to iHep conversion
(Figure 3A). Careful analysis of the derived cells showed that we
attained comparable derivation efficiency and that the cells ex-
pressed E-cadherin and albumin, stored glycogen, took up
low-density lipoprotein (LDL), secreted albumin, and produced
urea (Figures S3A–S3F). As previously reported, we observed
emergence of epithelial-like iHep colonies 3 weeks following
transduction and culture on collagen-coated plates. Moreover,
these cells were immortalized, in accordance with the previous
report, and we have been able to continuously passage estab-
lished iHep lines for over a year. These analyses confirm that
our iHeps appear equivalent to those previously reported (Sekiya
and Suzuki, 2011). Ex vivo cultured primary hepatocytes are
known to dedifferentiate (Strain, 1994). qPCR analysis of key
liver markers in iHeps showed very weak hepatic gene expres-
sion relative to both freshly isolated primary and dedifferentiated
hepatocytes, and much higher levels of Afp and E-cadherin (Fig-
ure S3G). The failure of iHeps to reach expression levels of even
dedifferentiated primary hepatocytes suggests that their inade-
quacy is not due to culture conditions alone.
We next transcriptionally profiled our iHeps and applied the
classification function of CellNet. iHeps classified predominantlyPrioritization Functions to B Cell to Macrophage Conversion
lishment, we devised a precise metric of GRN status. We defined this metric as
nd then weighted each gene (g1–g6) by its importance to the network and its
ence Score integrating the target expression level of the regulator, the extent of
the number of predicted targets. We applied these functions of CellNet to the
ed following conversion. The HPSCGRN is transiently and partially established
aintained in induced macrophages.
NA knockdown of Ebf1 andPou2af1: flow cytometry plots ofMac1 andCD302
ed following Ebf1 and Pou2af1 knockdown.
ockdowns: still images of cell morphology from timelapse imaging. Scale bars,
rresponding B cell andmacrophageGRN establishment (H). * = p < 0.05, t-Test.
ean ± SD.
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Figure 3. Application of CellNet to Direct Conversion of Fibroblasts to Hepatocytes
(A) Overview of Foxa1- and Hnf4a-driven generation of induced hepatocytes
(B) Cell and tissue classification heatmap of three independently derived iHep lines, fetal liver, and adult liver: iHeps poorly classify as liver.
(C) Liver and fibroblast GRN status in iHeps, fetal liver, and adult liver: the fibroblast GRN is not extinguished and liver GRN not fully established in iHeps. HSPC
classification of the fetal liver reflects its role as a hematopoietic organ at this stage.
(D) Partial establishment of a colon sub-GRN (424 genes) in iHeps. Data are represented as mean ± SD.
(E) Prioritization of transcriptional regulators of the colon GRN overexpressed in iHeps relative to native liver, led by the master intestinal regulator, Cdx2.
(F) Confirmation of intestine-specific gene expression in iHeps relative to native fibroblasts, liver, and colon. Data are represented as mean ± SEM.
See also Figure S3.as fibroblasts and barely manifested any liver classification (Fig-
ure 3B; mean scores: 0.186 and 0.049, respectively). CellNet
analysis of GRN status in these cells confirmed that fibroblast
status was not extinguished while liver identity was only weakly
established (Figure 3C). This classification was not accounted
for by incomplete conversion nor the persistence of fibroblasts,894 Cell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc.as the rapidly dividing iHeps dominate the culture. Considering
our accompanying findings that alternate cell fates are estab-
lished in most fate engineering protocols, we assessed all
alternate identities suggested by CellNet (Cahan et al., 2014).
Unexpectedly, CellNet detected the partial establishment of an
intestinal GRN, relating to colon (Figure 3D).
Intestinal Fate Specification in iHeps
During endoderm development, liver is derived from foregut
and intestine from hindgut (Sheaffer and Kaestner, 2012).
Considering our findings that knockdown of B cell transcriptional
regulators could derepress macrophage fate, we reasoned that
factors responsible for a hindgut program in iHeps may act to
repress specification of foregut fate. We consulted CellNet and
found that the homeobox transcription factor Cdx2 emerged as
the top prioritized regulator of colon fate in iHeps (Figure 3E).
Cdx2 is a regulator of Hox gene expression that is required for in-
testinal cell lineage specification in early endoderm (Gao et al.,
2009). Interestingly, CellNet also revealed several Hox genes as
prioritized regulators of the colon GRN, suggesting that iHeps
were aberrantly patternedwith respect to theHox code.Whereas
freshly-isolated adult hepatocytes did not express Cdx2, we
confirmedexpression ofCdx2 and additional CellNet-nominated,
intestine-specific marker genes in three independent iHep lines,
consistent with expression data previously reported for iHeps
(Sekiya and Suzuki, 2011; Figures 3F, S4A, and S4B).
Cdx2 Is Required for the Generation of iHeps
Cdx2 expression in posterior gut epithelium antagonizes foregut
differentiation (Gao et al., 2009). Thus we proceeded to knock
down Cdx2 in iHeps in an attempt to fortify their liver identity.
As predicted, we observed significant loss of CellNet-appointed
intestine-specific gene expression, with more efficient Cdx2
knockdown resulting in reduced intestinal marker expression
(Figures 4A and S4C: Cdx2low, 85% knockdown). Moreover,
knockdown ofCdx2 resulted inmoderate increases in expression
of the liver markers Albumin, Afp, and alpha-1 antitrypsin (a1AT)
(Figure 4B). Functionally, following Cdx2 knockdown, albumin
expression and urea secretion significantly increased (Figures
4C and 4D). Additionally, Cdx2 knockdown resulted in higher
gene expression associated with liver functions and appeared
to alter the Hox code to favor anterior gene expression (Fig-
ure S4D). However, neither liver classification nor liver GRNstatus
improved following Cdx2 knockdown (Figure S4E). Interestingly,
these gains in liver-specific gene expression and function were
more evident for the weaker Cdx2 knockdown: Cdx2mod (Fig-
ure S4C: Cdx2mod, 60% knockdown). Cdx2 disruption has
been shown to disrupt Hnf4a occupancy at Cdx2-bound en-
hancers (Verzi et al., 2013) and analysis of our iHep microarray
data revealed that expression of endogenous Hnf4a was lost as
Cdx2 expression decreased, suggesting coordinate regulation
of these two factors during iHep induction (Figure 4E).
To furtherprobe the roleofCdx2 infibroblast to iHepconversion,
we attempted to derive iHeps from MEFs carrying exon 2 of the
Cdx2 gene flanked by loxP sites (Verzi et al., 2010; Figure S5A).
Following transductionwith EGFP-Cre to knock outCdx2, we initi-
ated direct conversion to iHeps with Foxa1 and Hnf4a. In the GFP
control, iHep colonies began to emerge after 7 days, whereas no
colonies were detected following Cdx2 knockout, demonstrating
that Cdx2 is necessary for the establishment of iHeps (Figure 4F).
Levels of Foxa1 and Hnf4a Are Important for Hepatic or
Intestinal Fate Specification
To understand how intestinal fate might be specified in iHeps,
and to identify candidate factors to further engineer the cells,we consulted CellNet to score transcriptional regulators of the
endoderm, liver, and colon GRNs. Interestingly, we found the
transcription factors used to generate iHeps to be putative reg-
ulators of a broad endoderm GRN, and Foxa1 in particular to
be more heavily biased toward targets in the endoderm and co-
lon GRNs than the liver GRN (Figure 5A). Surveying Foxa1 and
Hnf4a expression over all CellNet target cells and tissues reveals
their expression across a range of endoderm-derived tissues
and restriction of coexpression to liver, colon, and small intes-
tine. Indeed, the highest levels of Foxa1 expression are found
in the colon (Figure 5B). These data highlight the roles of these
transcription factors in both liver and intestinal tissues (Garrison
et al., 2006; Parviz et al., 2003). Together, this suggests that the
conversion factors employed in this protocol fail to establish a
unique liver fate but instead specify endoderm tissues more
broadly. This indicates that higher levels of Foxa1 and Hnf4a
may target a much broader endoderm GRN, resulting in the
establishment of colon GRNs in addition to liver GRNs.
To further investigate the effect of variable levels of reprogram-
ming factor expression, we employed retroviral infection at low
(6–12) and high (15–30) multiplicities of infection (MOI) for
Foxa1 and Hnf4a to drive conversion to iHeps. Low MOI pro-
moted conversion to cells that resemble native hepatocytes—
binucleate, possessing an orthogonal morphology distinct from
the epithelial morphology reported for iHeps (Sekiya and Suzuki,
2011; Figure 5C). In contrast, high MOI conditions, equivalent to
the conditions employed by Sekiya and Suzuki, generated col-
onies with characteristic iHep morphology that were capable
of expanding indefinitely (Figure 5C). Monitoring the behavior
of low MOI iHeps over the course of 6 days revealed that these
cells became quiescent after limited cell division, corresponding
to ex-vivo-cultured primary hepatocytes. Moreover, qPCR anal-
ysis of low MOI iHeps revealed reduced Cdx2 expression and
enhancedAlb expression relative to highMOI iHeps (Figure S5B).
Supplementing low MOI Foxa1 and Hnf4a infection with exoge-
nous Cdx2 permitted the establishment of large iHep colonies,
whereas in the absence of Cdx2 no E-cadherin-positive epithe-
lial colonies were generated (Figure 5D and S5C).
These data further corroborate the importance of Cdx2
expression for the conversion of MEFs to iHeps, and suggests
that different levels of Foxa1, Hnf4a, and Cdx2 might establish
alternate endodermal cell fates. Furthermore, our analysis shows
a greater number of Foxa1 and Hnf4a targets in the endoderm
and colon, relative to liver. Given the close association of these
transcription factors to hindgut fate, we decided to further inves-
tigate the intestinal potential of iHeps.
Intestinal Fate and Function of iHeps
To explore the potential for iHeps to form epithelial structures
in vitro, we cultured iHeps as 3D organoids, which could be
expanded from single cells in matrigel to form large spherical
structures possessing epithelial polarity and whose formation
was dependent on Cdx2 expression (Figures 6A and S6A). How-
ever, neither prolonged culture nor the addition ofWnt3a resulted
in budding structures characteristic of organoids grown from
adult intestinal stemcells (Yui et al., 2012; Figure S6A).Moreover,
Lgr5 positive cells, indicative of adult intestinal stem cells, were
only rarely detected in iHeps cultured under these conditions,Cell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc. 895
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Figure 4. Requirement of Cdx2 for Function and Generation of iHeps
(A and B) qPCR analysis of intestine-specific (A) and liver-specific (B) gene expression following Cdx2 knockdown.
(C and D) Albumin expression (C) and urea production (D) in iHeps following Cdx2 knockdown. * = p < 0.05, *** = p < 0.001, t-Test. Cdx2 knockdown in iHeps
reduces intestinal gene expressionwhilemoderately increasing liver gene expression and function, although these gains diminish with strongerCdx2 knockdown.
(E) Correlation between endogenous Hnf4a and Cdx2 expression in several iHep lines.
(F) Fibroblasts fail to be converted to iHeps in the absence of Cdx2: Foxa1 and Hnf4a transduction of conditional Cdx2 knockout fibroblasts. Far right: Cre
expression does not impair generation of iHeps. Scale bars, 50 mM. Data are represented as mean ± SEM.
See also Figure S4 and S5.and their culture could be maintained in the absence of R-spon-
din and Wnt3a (Figure S6B). Although distinct from intestinal
stem cells, the morphology and behavior of iHeps was reminis-
cent of fetal enterospheres, whichmay represent transient devel-
opmental intestinal progenitors (Fordham et al., 2013).896 Cell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc.iHeps Functionally Engraft Colon
iHeps can functionally engraft liver, and over time within this
in vivo niche, they cease to divide and their hepatocyte gene
expression signature matures (Sekiya and Suzuki, 2011).
Considering that our iHeps formed spheroids and resembled
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Scale bars, 50 mM. See also Figure S5.intestinal progenitors in 3D matrigel culture, we wondered if they
might differentiate further toward mature intestine. We again
consulted CellNet for candidate transcriptional regulators to
drive iHeps closer to intestine and identified Klf4 and Klf5, whose
functions are known in the differentiated epithelium and dividing
crypt cells, respectively (McConnell et al., 2007). We then drove
the conversion of MEFs to an intestinal fate using high-MOI
Hnf4a and Foxa1 supplemented with either Klf4 or Klf5. Addition
of either Klf transcription factor dampened liver marker expres-
sion and strongly fortified intestinal identity, without altering
fibroblast-specific gene expression significantly (Figure 6B).
Taken together, these data show that iHeps generated by the
published protocol of Sekiya and Suzuki can differentiate toward
both liver and intestine, suggesting that iHeps are actually
induced endoderm progenitors, ‘‘iEPs.’’ To test the potential
for iHeps/iEPs and Klf-matured cells (termed ‘‘Klf-iEPs’’) todifferentiate toward functional intestinal cells in vivo, we trans-
planted GFP-labeled iHeps/iEPs, Klf-iEPs, and fibroblasts into
superficially damaged mouse colon, a model recently employed
to assess the functional engraftment of ESC-derived intestinal
stem cells (Yui et al., 2012; Figure 6C). Following 6 days of
DSS-induced colitis and 48 hr of recovery, 5 million cells were
delivered into the lumen of the colon, twice over a 2 day period,
and the colon was examined for cellular engraftment 12 days
later. During this period control animals receiving fibroblasts
had not returned to their original weight, demonstrated ongoing
colitis resulting in death of 2/6 mice, and showed no engraft-
ment. In contrast, iHep/iEP recipient animals returned to their
original weight significantly faster, showed no sign of colitis after
12 days, and instead revealed the presence of numerous GFP+
donor-derived cells integrated into the colonic epithelium (Fig-
ures 6C–6E). Klf-iEPs did not engraft the colon (Figure S6C),Cell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc. 897
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probably because mature intestinal epithelial cells cannot fulfill
this role (Zhou et al., 2012). At 12 days, crypts contained a mix
of GFP+ and GFP colonocytes, as the known cell turnover
would predict (Figure 6D). By 7weeks after transplantation, how-
ever, five of eight recipient mice carried patches of GFP+ colonic
crypts (Figure S6D), which signifies competent reconstitution of
the damaged mucosa by iHep/iEPs. The patchy pattern of GFP+
crypts strongly indicates clonal repopulation by cells with intes-
tinal stem-like self-renewal (Figures 6F and 6G), and the lack of
Lgr5 expression in iHeps in vitro is compatible with low Lgr5
gene activity in native mouse colonic crypts, distinct from the
small intestine (Barker et al., 2007).
To evaluate if iHeps/iEPs could mature in vivo, we harvested
colonic crypts from recipient animals 12 days posttransplanta-
tion, dissociated the colonic epithelium, and profiled gene
expression in GFP+ cells purified by flow cytometry (Figure S6E).
By CellNet analysis, colon-engrafted iHeps/iEPs received a high
colon classification score, significantly stronger than iHeps
cultured in vitro prior to engraftment (average colon scores
0.79 and 0.07, respectively) and a weaker small intestine classi-
fication score of 0.33 (Figure 6H). Both the fibroblast GRNpersis-
tent in iHeps/iEPs and their weak liver GRN were significantly
silenced, with an accompanying slight increase in small intestine
GRN status and striking fortification of the colon GRN to 90% of
the native colon status (Figure 6I). To rule out fusion of iHeps/
iEPs with native colonic cells, we transplanted EGFP-Cre trans-
duced iHeps/iEPs into Rosa26-Lox-STOP-Lox-Tomato trans-
genic mouse colons: engrafted cells did not exhibit tomato fluo-
rescence, dismissing this formal possibility (Figure S6F). The
long-term functional engraftment of iHeps/iEPs into superficially
damaged mouse colon, along with the previously reported func-
tional engraftment within mouse liver (Sekiya and Suzuki, 2011),
establishes that these cells represent progenitors with broad
endodermal rather than hepatocyte-restricted potential. Thus
we demonstrate how the CellNet network biology platform
guided a direct conversion strategy to generate endoderm pro-
genitors capable of functional intestinal repopulation.
DISCUSSION
Here, in a practical application of CellNet to two distinct cell fate
conversion protocols, we document the incomplete specifica-
tion of macrophage fate in a B cell line, and the unexpectedFigure 6. iHeps Are an Endoderm Progenitor Harboring Intestinal Iden
(A) Culture of iHeps as spheroids and determination of cell polarity by immunoflu
(B) qPCR analysis of fibroblast, liver and intestinal gene expression following three
are represented as mean ± SEM.
(C) Functional engraftment of GFP-expressing iHeps into mice with DSS-induce
mals: the latter regain weight significantly faster than recipients of GFP-fibroblas
(D) Immunohistochemistry and immunofluorescence of short-term engrafted GF
(E) Whole-mounts of engrafted GFP-iHeps/iEPs. Engraftment of GFP-fibroblasts
(F) Long-term engrafted GFP-iHeps/iEPs in the colon 7 weeks after transplantati
(G) Detail of long-term engrafted crypt.
(H) CellNet classification of engrafted iHeps/iEPs recovered 12 days following tra
comparable to native colon, relative to in vitro cultured iHeps/iEPs.
(I) Fibroblast, liver and broad colon GRN status in colon-engrafted iHeps/iEPs: F
following maturation in vivo. Data are represented as mean ± SD.
Scale bars as indicated. See also Figure S6.establishment of intestinal identity in fibroblasts reportedly con-
verted into liver. CellNet analysis yielded the surprising discovery
that iHeps in fact represent an induced endoderm progenitor
(‘‘iEP’’), which is capable of long-term functional engraftment
of the mouse colon. Additional manipulation of CellNet-priori-
tized candidates, Klf4 and Klf5, promoted intestinal maturation
in vitro, but these differentiated ‘‘Klf-iEP’’ cells failed to engraft
damaged colon, indicating that cell populations engineered
in vitro must be transplanted at a specific stage that is amenable
to functional end organ engraftment (Figure 7).
Our findings establish CellNet as a potent tool for assessing
the fidelity of cell fate conversions and for revealing unexpected
properties of cells engineered in vitro. CellNet analysis calls into
question the underlying premise that direct conversion bypasses
progenitor or stem cell intermediates. First, in B cell to macro-
phage conversion, we found that progenitor GRNs were partially
and transiently engaged, suggesting that C/EBPa has the ca-
pacity to establish a progenitor-like program from which macro-
phage fate emerges. Second, we demonstrate that iHeps are
endoderm progenitors, iEPs, rather than mature hepatocyte-
like cells as previously reported (Sekiya and Suzuki, 2011).
Additionally, there have been several reports describing the gen-
eration of progenitors from direct conversion of fibroblasts: he-
matopoietic, neural, and hepatic progenitors (Lujan et al.,
2012; Pereira et al., 2013; Yu et al., 2013). The capture of a pro-
genitor state in vitro may be facilitated by selection for these
expandable populations over nondividing differentiated cells.
The existence of iHeps as endoderm progenitors rather than
differentiated cells explains their failure to exclusively classify
as a unique cell or tissue until they mature within the colon niche.
Our accompanying study shows that cells derived via directed
differentiation more faithfully establish the desired target GRNs
relative to direct conversion (Cahan et al., 2014). It is possible
that cells generated via direct conversion classify poorly
because this approach frequently specifies progenitors that
must be subsequently differentiated. The resolution and power
of CellNet to accurately identify these intermediates will continue
to improve as sufficient training data sets are collected for em-
bryonic lineages. At present, we can assert that in vitro cultured
iHeps/iEPs are neither mature liver nor colon but behave as a
progenitor, although their in vivo equivalent is unclear.
Pancreas and lung GRNs were not detected in iHeps/iEPs,
suggesting that their potential may be restricted to liver andtity and Can Functionally Engraft Mouse Colon
orescence staining of E-cadherin.
-factor driven conversion to ‘‘Klf-iEPs’’ with Hnf4a, Foxa1, and Klf4 or Klf5. Data
d colitis. Weight gain following DSS withdrawal in GFP-iHep/iEP recipient ani-
ts, ** = p < 0.01, *** = p < 0.001, t test. Data are represented as mean ± SEM.
P-iHeps/iEPs in serial sections of colon 12 days after transplantation.
is not observed. Scale bars, 0.5 cm.
on. Goblet cells are visualized by PAS staining. Scale bars, 100 mm.
nsplantation. Colon classification is strongly fortified in engrafted iHeps/iEPs,
ibroblast and liver GRNs are extinguished where colon GRN status is fortified
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Figure 7. Model: Foxa1 and Hnf4a Specify an Endoderm Progenitor State
Left: In this studywe find that low levels of Foxa1 andHnf4a expression in fibroblasts in vitro specifies cells bearing the hallmarks of differentiated hepatocytes. High
levels of Foxa1 and Hnf4a specifies a progenitor state, ‘‘iHeps/iEPs’’ from which differentiation toward an intestinal fate, ‘‘Klf-iEPs,’’ can be coaxed by Klf4/5
expression. Right: iHeps/iEPs can engraft mouse liver (as in Sekiya and Suzuki, 2011) or mouse colon. Transplantation into colon leads to differentiation of pro-
genitors to support long-term engraftment suggesting that iHeps/iEPs possess intestinal stem-like properties.intestine. Hnf4a is required for development of the liver (Parviz
et al., 2003) and colon (Garrison et al., 2006). Similarly, Foxa1
is involved in liver and intestinal development and function (Ber-
nardo and Keri, 2012). Foxa1 is a pioneer factor, capable of re-
modeling chromatin and facilitating binding of other transcription
factors, such as Hnf4a (Zaret and Carroll, 2011). In a variation
to the protocol of Sekiya and Suzuki, we found that lower ex-
pression of Foxa1 and Hnf4a generates cells resembling native
hepatocytes. In contrast, high levels of Foxa1 may facilitate a
permissive chromatin state accessible to Hnf4a thus establish-
ing an embryonic endoderm progenitor state (Figure 7).
CellNet prioritized Cdx2 as an intestinal fate regulator in iHeps/
iEPs, leading to the finding that Cdx2 is essential to establish the
endoderm progenitor state in these cells. Cdx2 specifies embry-
onic intestinal epithelium and is required for intestinal gene
expression, including Hnf4a (Gao et al., 2009). By E9.0 emer-
gence of Cdx2 in the hindgut and Sox2 in the foregut demarcates
the endoderm (Sherwood et al., 2009), suggesting that iHeps/
iEPs may more resemble a hindgut progenitor. iHep/iEP behavior
in vitro is reminiscent of recently reported fetal enterospheres
(Fordhamet al., 2013), a transient intestinal progenitor population,
rather than adult intestinal stem cells, further supporting the
notion that high levels of Foxa1 and Hnf4a install a hindgut pro-
genitor state. The capacity of iHeps to engraft liver raises the pos-
sibility that a foregut progenitor is concomitantly specified,
although our failure to isolate any expandable progenitor popula-
tion in the absence of Cdx2 expression does not support this.
Likewise, any lowMOI hepatocyte-like cells are unlikely to engraft
liver due to their scarcity and selection against in vitro. It must also
be emphasized that direct conversion is an artificial situation
where high levels of pioneer factor expressionmay open inacces-
sible chromatin domains to endow cells with enhanced plas-
ticity—thus iHeps/iEPs may not possess a true in vivo correlate.
In addition to assigning a metric of cell identity and thereby
providing a measure of the fidelity of cell fate conversions,
CellNet prioritizes candidates for interventions to help improve900 Cell 158, 889–902, August 14, 2014 ª2014 Elsevier Inc.cell-fate specification. At present, predicting gene expression
in GRNs remains challenging and is limited to simplified net-
works. Here, knockdown of prioritized B cell candidates,
Pou2af1 or Ebf1, improves the classification and function of
induced macrophages. Moreover, CellNet prioritization of regu-
lators of the colon GRN established in iHeps led to the discovery
that Cdx2 is required for the generation of iHeps, an instru-
mental finding helping reveal their full potential. Furthermore,
CellNet assisted in the identification of Klf4 and Klf5 as factors
to differentiate iHeps further toward mature colon in vitro. These
results demonstrate the utility of CellNet to dissect and enhance
cell engineering strategies. However, it is clear from the
outcome of our interventions that refining cell identity is not triv-
ial, as illustrated by the persistence and fortification of B cell
GRNs following knockdown of prioritized B cell regulators.
Due to this complex feedback regulation within GRNs, attempt-
ing to refine engineering strategies will require a painstaking,
rational, iterative approach.
Undoubtedly, the best strategy to capture a desired fate har-
nesses the in vivo niche. In our accompanying study, our analysis
shows that cardiomyocyte-like cells generated from cardiac fi-
broblasts in situ (Fu et al., 2013) show a markedly higher heart
classification than those converted in vitro (Cahan et al., 2014).
Similarly, here we have shown that following engraftment into
colon, iHeps exhibited stem cell behavior to reconstitute the in-
testinal epithelium, maturing in vivo to increase their colon clas-
sification, associated with 90% colon GRN establishment and
silencing of liver and fibroblast GRNs. Achieving such a high
degree of tissue identity in vivo may be ideal for therapeutic ap-
plications of engineered cells, but for in vitro applications in toxi-
cology testing and disease modeling, it will be essential to
develop more robust cell fate conversions. Understanding how
in vivo cues mature fate will assist in this endeavor, as will bioen-
gineering approaches designed to recapitulate the niche in vitro.
CellNet analysis will be of great assistance in developing these
strategies.
This study establishes CellNet as a powerful platform for as-
sessing and refining engineered cell populations. In addition to
providing a metric for the establishment of target cell identity,
CellNet can reveal the unanticipated hybrid or intermediate iden-
tity of cells, which can be easily overlookedwith current methods
of broad transcriptional profiling and functional assays. This
approach has revealed the unrealized potential of iHeps as an
endoderm progenitor and establishment of intestinal fate from
a direct conversion strategy. In the future, we anticipate
continued refinement of CellNet and greater potential to marshal
cellular engineering toward more precise and impactful applica-
tions in regenerative medicine.
EXPERIMENTAL PROCEDURES
Extended Experimental Procedures are available online.
Mice
Strains used in this study: C57BL/6J (The Jackson laboratory: 000664),
C;129S4-Rag2tm1.1Flv Il2rgtm1.1Flv/J (The Jackson laboratory: 014593),
B6.129P2-Lgr5tm1(cre/ERT2)Cle/J (The Jackson laboratory: 008875), B6;129S6-
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (The Jackson laboratory: 007905), and
Cdx2Flox/Flox (Verzi et al., 2010). All animal procedures were based on animal
care guidelines approved by the Institutional Animal Care and Use Committee.
Direct Conversion of B Cells to Macrophages
The C10 pre-B cell line was converted to induced macrophages, as in Buss-
mann et al. (2009). Briefly, C10 cells were grown in RPMI 1640 without phenol
red (Lonza) supplemented with 10% charcoal/dextran-treated FBS (Hyclone)
and 50 mM 2-mercaptoethanol (GIBCO). They were induced by the addition
100 nM of b-estradiol (Sigma) and grown with 10 nM IL-3 and mCSF-1
(Peprotech).
Direct Conversion of MEFs to iHeps
MEFs were converted to iHeps as in Sekiya and Suzuki (2011). Briefly, MEFs
were prepared from E13.5 embryos and serially transduced with Foxa1 and
Hnf4a or Hnf4a-t2a-Foxa1 retroviruses over a 5 day period, followed by cul-
ture on gelatin for 2 weeks in hepato-medium (DMEM:F-12, supplemented
with 10% FBS, 1 mg/ml insulin (Sigma), 1027M dexamethasone (Sigma-Al-
drich), 10 mM nicotinamide (Sigma-Aldrich), 2 mM L-glutamine, 50mM b-mer-
captoethanol (Life Technologies), and penicillin/streptomycin, containing
20 ng/ml hepatocyte growth factor (Sigma-Aldrich), and 20 ng/ml epidermal
growth factor (Sigma-Aldrich), after which the emerging iHeps were cultured
on collagen. iHeps generated with mono- and bicistronic constructs were
indistinguishable both transcriptionally and functionally.
Lenti- and Retrovirus Production
Open reading frames were cloned into the lentiviral vector, pSMAL-GFP or the
retroviral vector, pGCDNsam. Lentiviral particles were produced by transfect-
ing 293T-17 cells (ATCC: CRL-11268) with pCMV-dR8.2 dvpr (Addgene
plasmid 8455), and pCMV-VSVG (Addgene plasmid 8454). Virus was har-
vested 48 and 72 hr after transfection and PEG concentrated. Constructs
were titered by serial dilution on 293T cells. Foxa1, Hnf4a, and Hnf4a-t2a-
Foxa1 retroviruses were packaged with pCL-Eco (Imgenex), titered on
MEFs, and cells transduced according to Sekiya and Suzuki (2011).
Gene Expression Microarray
The RNAeasy Microkit (QIAGEN) was used to collect and prepare total RNA for
microarray analysis. The Ovation Picokit (Nugen) was used for preamplifica-
tion, where required. Gene expression profiling was performed on Affymetrix
430 2.0 gene chips per standard protocol.
Conditional Cdx2 Knockout
E13.5 MEFs were derived from Cdx2Flox/Flox embryos (Verzi et al., 2010),
transduced with either EGFP or EGFP-Cre retrovirus (Addgene plasmid24064), cultured for 48 hr, and then GFP+ cells were flow sorted and
cultured on gelatin. The cells were then transduced with Foxa1 and Hnf4a
retroviruses.
Immunohistochemistry and Immunostaining
Cultured cells were fixed with 4% PFA, permeabilized, blocked in 10% FCS
and incubated with the following antibodies: mouse anti-E-cadherin (BD
Biosciences) and rabbit anti-Albumin (Biogenesis). After washing, samples
were incubated with Alexa 568-conjugated secondary antibody (1:500;
Molecular Probes) with DAPI and far-red phalloidin (Molecular Probes) for
immunofluorescence staining. Colon tissue was fixed with 10% formalin
and paraffin sectioned. After rehydration and blocking in 10% goat serum,
the sections were incubated with rabbit anti-GFP antibody (Abcam:
ab6556). For immunofluorescence analysis, the sections were incubated
with Alexa 488-conjugated secondary antibody (1:500; Molecular Probes)
and DAPI and imaged with a Zeiss LSM 710 confocal microscope. For
immunohistochemistry, samples were processed using the Vectastain
ABC system and DAB kit (Vector Laboratories), and PAS staining was per-
formed with a kit (Sigma).
Intracolonic Transplantation of iHeps
Colitis was induced in Rag2gc/mice by administration of 2.5% Dextran So-
dium Sulfate (DSS, MP Biomedicals) in the drinking water for 6 days, followed
by 2 days of recovery. On day 8, animals losing between 15%–20% of their
original body weight were selected at random to receive delivery of 5 million
cells (GFP-labeled iHeps, fibroblasts or Klf4-iEPs) into the lumen of the colon.
In a modification to the procedure reported in Yui et al. (2012), the cells were
resuspended in Matrigel (BD Biosciences) and 100–150 ml of the suspension
was delivered via a 22G angiocatheter (BD Biosciences). Transplantation of
cells was repeated on day 10 and the colons were examined for engraftment
on day 20 and week 7 postinitiation of DSS treatment. For recovery of GFP-ex-
pressing iHeps, transplanted colons were cut into small pieces and incubated
in HBSS with 30 mM EDTA at 37C to liberate crypts. The crypts were then
dissociated with 0.25% Trypsin and the resulting single-cell suspension was
flow sorted to recover engrafted iHeps.
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